Open Access Articles

Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*




Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation

, 2018; 13(2): 133 - 144

Juan F. Santibanez* and Suncica Bjelica




Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86 - 105

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*




Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy

, 2018; 13(1): 2 - 17

Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*




Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage

, 2018; 13(1): 18 - 39

So-Yeon Park, Ji-Young Kim, Youngsoo Jun and Jeong-Seok Nam*




From a Better Understanding of the Mechanisms of Action of Histone Deacetylases Inhibitors to the Progress of the Treatment of Malignant Lymphomas and Plasma Cell Myeloma

, 2017; 12(4): 283 - 295

Romeo G. Mihaila*




Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens

, 2017; 12(2): 136 - 147

Zsuzsanna Suba*




Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery*

, 2016; 11(3): 254 - 266

Zsuzsanna Suba




Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

, 2016; 11(2): 184 - 196

Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian Luo




Cabozantinib in Thyroid Cancer

, 2015; 10(3): 259 - 269

Poupak Fallahi, Silvia M. Ferrari, Flavia Di Bari, Gabriele Materazzi, Salvatore Benvenga, Paolo Miccoli and Alessandro Antonelli




Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women

, 2013; 8(2): 154 - 167

Zsuzsanna Suba




Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion

, 2011; 6(3): 311 - 323

Sarah Shirley, Alexandre Morizot and Olivier Micheau




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science